Previous 10 | Next 10 |
home / stock / cvs / cvs articles
Humana Inc (NYSE:HUM) shares nosedived after the company released dismal fourth quarter 2023 earnings. The company reported a Q4 adjusted...
The two investments will reduce the company's carbon footprint by nearly 114,000 metric tons annually WOONSOCKET, R.I., Jan. 25, 2024 /PRNewswi...
The Federal Reserve is driving the market bus. Rate cut expectations have been re-drawn, and the “buy everything” sentiment that powere...
Healthcare insurance firm Humana Inc (NYSE:HUM) cut its fiscal 2023 earnings outlook as the costs of members’ care exceeded its exp...
In the current market session, CVS Health Inc. (NYSE:CVS) share price is at $76.58, after a 2.98% drop. Over the past month, the stock went up by 0...
CVS Health Corp (NYSE:CVS) is reportedly looking to close some of its pharmacies located within Target Corporation (NYSE:TGT) s...
The FDA has allowed Florida to import prescription drugs from Canada, potentially altering the landscape of how Americans access and affo...
Consulting giant McKinsey & Co, on Friday, agreed to a settlement of $78 million to resolve allegations tied to the opioid epidemic, as di...
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. The forthcoming year will provide the first...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...